Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.

Haddad AQ, Kapur P, Singla N, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Sagalowsky A, Lotan Y, Margulis V.

Cancer. 2015 Jan 1;121(1):43-50. doi: 10.1002/cncr.28976. Epub 2014 Sep 3.

PMID:
25186283
[PubMed - in process]
2.

BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.

Kapur P, Christie A, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Xie XJ, Lotan Y, Margulis V, Brugarolas J.

J Urol. 2014 Mar;191(3):603-10. doi: 10.1016/j.juro.2013.09.041. Epub 2013 Sep 25.

PMID:
24076305
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk